Eggshell Membrane: Conclusions | Precision Nutrition

What Did We Learn?

In conclusion, the three human trials to date (including the present study) have demonstrated statistically significant and clinically relevant improvements in joint pain using 500mg of EM daily.

Although more research is needed to further document these effects, as well as to clarify the mechanism of action of EM, the current body of evidence suggests that those who suffer from chronic joint pain may benefit from EM and FJC+ as an alternative therapy for chronic joint pain and perhaps other JCT disorders.